Hyowon Lee Selected Research

1- palmitoyl- 2- linoleoyl- 3- acetyl- rac- glycerol

6/2022	PLAG alleviates cisplatin-induced cachexia in lung cancer implanted mice.
1/2022	PLAG co-treatment increases the anticancer effect of Adriamycin and cyclophosphamide in a triple-negative breast cancer xenograft mouse model.
1/2022	Suppression of tumor progression by thioredoxin-interacting protein-dependent adenosine 2B receptor degradation in a PLAG-treated Lewis lung carcinoma-1 model of non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hyowon Lee Research Topics

Disease

5	Neoplasms (Cancer) 07/2022 - 09/2021
3	Gliosis 01/2024 - 06/2021
2	Opiate Overdose 11/2023 - 01/2019
2	Respiratory Insufficiency (Respiratory Failure) 11/2023 - 01/2019
2	Cognitive Dysfunction 01/2023 - 01/2021
2	Hematoma 01/2022 - 11/2021
2	Body Weight (Weight, Body) 01/2022 - 01/2021
2	Hydrocephalus (Hydrocephaly) 11/2021 - 08/2014
2	Foreign Bodies (Foreign Body) 01/2021 - 02/2020
2	Nervous System Diseases (Neurological Disorders) 06/2020 - 06/2020
2	Spinal Cord Injuries (Spinal Cord Injury) 04/2019 - 01/2019
1	Neuroinflammatory Diseases 01/2024
1	Hypoxia (Hypoxemia) 11/2023
1	Mental Disorders (Mental Disorder) 10/2023
1	Chronic Disease (Chronic Diseases) 09/2023
1	Alzheimer Disease (Alzheimer's Disease) 01/2023
1	Aneurysm (Aneurysms) 06/2022
1	Cachexia 06/2022
1	Weight Loss (Weight Reduction) 06/2022
1	Lung Neoplasms (Lung Cancer) 06/2022
1	Triple Negative Breast Neoplasms 01/2022
1	Hemorrhagic Stroke 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Glaucoma 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Hemorrhage 11/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Parkinsonian Disorders (Parkinsonism) 01/2021
1	Obesity 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Hyperuricemia 01/2020
1	Fatigue 09/2019

Drug/Important Bio-Agent (IBA)

4	Glutamic Acid (Glutamate)FDA Link 06/2020 - 01/2019
3	1- palmitoyl- 2- linoleoyl- 3- acetyl- rac- glycerolIBA 06/2022 - 01/2022
2	gamma-Aminobutyric Acid (GABA)IBA 01/2024 - 01/2023
2	Naloxone (Narcan)FDA LinkGeneric 11/2023 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2020
1	Messenger RNA (mRNA)IBA 01/2024
1	LipopolysaccharidesIBA 01/2024
1	Narcotic Antagonists (Opioid Antagonists)IBA 11/2023
1	Opioid Analgesics (Opioids)IBA 11/2023
1	SolutionsIBA 11/2023
1	Blood Glucose (Blood Sugar)IBA 09/2023
1	Insulin (Novolin)FDA Link 09/2023
1	Acetates (Acetic Acid Esters)FDA Link 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2023
1	Amyloid (Amyloid Fibrils)IBA 01/2023
1	CytokinesIBA 07/2022
1	ChemokinesIBA 07/2022
1	Smart MaterialsIBA 06/2022
1	Cisplatin (Platino)FDA LinkGeneric 06/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2022
1	Interleukin-6 (Interleukin 6)IBA 06/2022
1	Adenosine (Adenocard)FDA LinkGeneric 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	ThioredoxinsIBA 01/2022
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2022
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2022
1	SuspensionsIBA 09/2021
1	HydrogelsIBA 09/2021
1	SynucleinsIBA 06/2021
1	Fibronectins (Fibronectin)IBA 01/2021
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2021
1	Monoamine Oxidase (MAO)IBA 01/2021
1	AntioxidantsIBA 01/2021
1	PolymersIBA 01/2021
1	Neuroprotective AgentsIBA 01/2021
1	olive leaf extractIBA 01/2021
1	Biocompatible Materials (Biomaterials)IBA 01/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 06/2020
1	Uric Acid (Urate)IBA 01/2020
1	C-Reactive ProteinIBA 01/2020
1	HydrogenIBA 09/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2019
1	Biomarkers (Surrogate Marker)IBA 04/2019
1	AntidotesIBA 01/2019
1	Sucrose (Saccharose)IBA 01/2019

Therapy/Procedure

3	Therapeutics 10/2023 - 09/2021
3	Catheters 01/2022 - 08/2014
2	Drug Therapy (Chemotherapy) 06/2022 - 01/2022
1	Wearable Electronic Devices 11/2023
1	Hydrophilic Contact Lenses (Hydrophilic Contact Lens) 01/2022
1	Ventriculoperitoneal Shunt 11/2021
1	Precision Medicine 09/2021